Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1700508 | 1.00 | BCL2 (1.00) | BCL2 | |
| SCHEMBL31344644 | 0.94 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1700557 | 0.94 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1700560 | 0.94 | BCL2 (1.00) | BCL2 | |
| SCHEMBL30313991 | 0.94 | BCL2 (0.89) | BCL2 | |
| SCHEMBL1701536 | 0.94 | BCL2 (0.89) | BCL2 | |
| SCHEMBL1812774 | 0.94 | BCL2 (0.88) | BCL2 | |
| SCHEMBL1700825 | 0.94 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1700829 | 0.94 | BCL2 (1.00) | BCL2 | |
| SCHEMBL1700827 | 0.94 | BCL2 (1.00) | BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682148-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Ireland Unlimited Company (IE) | 2026-01-21 | — | — | EP | disclosed |
| EP-4474383-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Ireland Unlimited Company (IE) | 2024-12-11 | — | — | EP | disclosed |
| EP-4218731-A2 | MELT-EXTRUDED SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT | AbbVie Ireland Unlimited Company (IE) | 2023-08-02 | — | — | EP | disclosed |